Orphan Drug Application presentation from the OOPD....incentives: grants and venture capital...hemaxellerate is a perfect match with the data to support....we have two full time Doctors finalizing the data and working the app when ready...pace should start to pick up around here, investors now are ahead of the market and foresee whats ahead.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.